Draft Agenda December 12, 2011 - Ignazio Marino

bewilderedvoyageBiotechnology

Dec 12, 2012 (4 years and 8 months ago)

150 views









Summit on Regenerative Medicine


An Italy
-
UK workshop

organised by the Italian Embassy in London

and the School of Science Technology and Health of the University Campus Suffolk


Monday 12 December 2011


University Campus Suffolk

Waterfront
Building, Neptune Quay

Ipswich IP4 1QJ







The ideal treatment of organs destroyed by the disease processes is replacement with new
organs or tissue. Cell therapy may be considered a natural extension of biopharmaceutical
technology; its therapeutic aspects encompass a wide range of technologies including stem
-
cell
technology, regenerative medicine, tissue engineering, medical devices, drug delivery, genetic
engineering, imaging and cell tracking. Stem cell technology promi
ses development of such
therapies based on the fundamental properties of these cells, self
-
renewal, plasticity,
differentiation, engraftment and regeneration.


While experimental and clinical results suggest that stem cell derived therapies are feasible an
d
may be beneficial, the consensus of the scientific community is that efficacy and safety is proven
only on a case
-
by
-
case basis. In particular, the challenges associated with the monitoring of cell
activity and location in the human body to meet the stri
ngent regulatory requirements of safety
and control are significant.


Enormous strides have been made in basic research of stem cell technology in the last decade.
Translating this technology into therapeutically feasible products will require concerted e
ffort and
partnering between academic, medical, and industrial bodies, in combination with supportive
government regulations and funding.


Now it is time for world
-
leading experts and managers from the UK, Italy and beyond to discuss
potential innovative
solutions in handling these issues. The summit will be based on
presentations which will offer the opportunity of sharing best practice, strategies of
implementation and future perspectives in developing this field. Its expected outcome is to reach
a commo
n understanding of the potential solutions available to cope with the critical unresolved
scientific, ethical, legal and regulatory challenges of translating the promise of stem cell therapy
into clinical practice.















Summit on Regenerative Medicine


An Italy
-
UK workshop

organised by the Italian Embassy in London

and the School of Science Technology and Health of the University Campus Suffolk


Monday 12 December 2011


University Campus Suffolk

Waterfront
Building, Neptune Quay

Ipswich IP4 1QJ


Preliminary Programme


8:00


8:30

Registration and refreshments



8:30



8:35


Introduction to the workshop

Salvator Roberto Amendolia
, Scientific Attaché, Italian Embassy in London


8:35



8:45


Welcome address

Mike Saks
; Provost and Chief Executive, University
Campus
Suffolk, UK


8:45



9:10

Keynote address

Chris Mason
, University College London, UK

Cell Therapy
-

The fourth and final pillar of healthcare


9:10



9:30

Opening speech




Charles Sabine
,
NBC War Correspondent




Why research matters
-

a layman's perspective



9:3
0


11:
5
0

From bench to b
edside


P
art I


Chair:

Brendon Noble
,
UCS Ipswich, UK



9:
3
0



Manal

Hadenfeld
, Bonn, Germany

Life and Brain
:

t
aking
s
tem cell
s

f
rom basic research to commercial application




9
:
4
5



Elena Cattaneo,
University of Milan, Italy


The
European effort in generating stem cell lines for neurodegenerative diseases



10:
00


Marc Peschanski
, I
-
STEM Evry, France

The I Stem model



10:15



10:
30

Coffee break



10:
30



Pasquale de Blasio
,

BioRep Milan, Italy

From a global network on Huntington's Disease to a European Pluripotent Stem Cell Bank
Network: the BioRep experience









Summit on Regenerative Medicine


An Italy
-
UK workshop

organised by the Italian Embassy in London

and the School of Science Technology and Health of the University Campus Suffolk


Monday 12 December 2011


University Campus Suffolk

Waterfront
Building, Neptune Quay

Ipswich IP4 1QJ


10:
45



Srabani Bhaumik
,
GE

Healthcare, Global Research Center, Niskayuna, NY, USA

Tracking cell fate, viability and differentiation


11:00




Ralf Menk
, Sincrotrone Elettra Trieste, Italy

and

Alessandro Olivo
,
UCL, UK

The development of innovative

imaging technologies to probe the mechanisms of tissue
regeneration in vivo


11:15


Simon Ellison
, NHS
UK

Tissue Bank


11:
30


11:45


Q&A





The political and ethical landscape


11
:45


George Freeman
, MP, UK



The UK perspective


12
:
0
0


Ignazio Marino
, President, Italian Senate Committee on NHS



An Italian perspective


12:15


Discussion



12:30


13:3
0

Lunch



13
:
3
0



14:45

From bench to
bedside


part II


Chair:
Elena Cattaneo
,

University of Milan, Italy



13:3
0


Brendon Noble
,

UCS Ipswich, UK




C
ell
-
based

therapies for cartilage repair



the work of the UCS Biotechnology Unit


13:4
5



Jane Lebkowski
,

Geron Corporation, Menlo Park CA,
USA

hESC
-
Derived Oligodendrocyte Progenitors for the Treatment of CNS Disorders:
Preclinical Studies and Phase 1 Clinical Trial


14:0
0


Pete Coffey
,

University College London, UK




Cell
-
based therapies
and eye diseases


14:1
5



John Martin
,University

College London, UK


TBC




Regenerative Medicine

for heart disease


14
:
3
0



14:4
5

Q&A










Summit on Regenerative Medicine


An Italy
-
UK workshop

organised by the Italian Embassy in London

and the School of Science Technology and Health of the University Campus Suffolk


Monday 12 December 2011


University Campus Suffolk

Waterfront
Building, Neptune Quay

Ipswich IP4 1QJ




14:45


15:1
5


Legal and
r
egulatory issues



14:4
5



Christian Schneider
, EMA
,
London




A European approach to
cell
-
based
therapy regulations


15
:0
0


Julian Hitchcock,
Field Fisher Waterhouse LLP, London; Director, CellFate




The Legal Challenge of Stem Cell Therapies



15:
1
5
-
1
5:3
0

Coffee break



15:3
0



16:1
5


The way forward



15:3
0



Trevor Jones
, UK Stem Cell Foundation




The UKSCF strategy for
stem cell research


15:4
5



Francesca Pasinelli
, Scientific Director, Telethon




The Telethon support to stem cell research


16:
0
0



Charles Kessler
, EU Commission
,
Brussels




The EU funding of stem cell research



16:
1
5



16:3
0

Concluding remarks